Fondation Maladies Rares Announces 2023 Call for Research on Rare Diseases of the Peritoneum
Fondation Maladies Rares is providing funding, in collaboration with AMARAPE, to French researchers to support study into rare diseases of the peritoneum.
The Fondation Maladies Rares (Foundation for Rare Diseases) is a non-profit umbrella organisation created in 2012 within the framework of France’s second National Rare Diseases Plan. Its overall mission is to promote, coordinate and support research on rare diseases to alleviate the social and therapeutic isolation of individuals afflicted with rare diseases and thus improve their daily life.
The Foundation, in partnership with l’Association contre les MAladies RAres du PÉritoine (AMARAPE – Association Against Rare Diseases of the Peritoneum) is offering funding to support an innovative, basic, translational or clinical research programme into rare diseases, primitive tumours and metastatic tumours of the peritoneum. Biomedical science and humanities and social science projects are also encouraged. All research aimed at increasing physiopathological understanding of the disease, improving diagnosis, developing better treatment processes and/or developing therapeutic strategies is welcome.
The scientific project leader (porteur principal) must be a researcher or a teaching researcher (enseignant-chercheur) affiliated with a French research institution. It is expected that the project leader be employed on a permanent contract at their institution. If they are not employed permanently, they must provide proof that their employment contract will run for the entire course of the project.
Funding of up to €30,000 is available to fund a research project for up to 24 months. Funding can cover the costs of temporary support staff. Equipment, operating and mission expenses are covered up to €2,000. Such expenses must be entirely and exclusively dedicated to the research project. Use of service providers must only make up a maximum of 10% of the budget.
Applications must be submitted by 29 June 2023.
(This report was the subject of a ResearchConnect Newsflash.)